| ORSAX | VSCIX | ORSAX / VSCIX | |
| Total Expense Ratio | 1.24 | 0.03 | 4,133% |
| Annual Report Gross Expense Ratio | 1.48 | 0.03 | 4,933% |
| Fund Existence | 3 years | 29 years | - |
| Gain YTD | 21.252 | 16.690 | 127% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 715M | 183B | 0% |
| Annual Yield % from dividends | 0.00 | 1.20 | - |
| Returns for 1 year | 32.77 | 24.73 | 132% |
| Returns for 3 years | 60.84 | 52.19 | 117% |
| Returns for 5 years | N/A | 35.23 | - |
| Returns for 10 years | N/A | 168.97 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JIESX | 22.78 | 0.47 | +2.11% |
| JPMorgan Developed International Value I | |||
| BHCUX | 22.73 | 0.45 | +2.02% |
| Baron Health Care R6 | |||
| SBHVX | 18.58 | -0.16 | -0.85% |
| Segall Bryant & Hamill Sm Cp Val Ins | |||
| RNNEX | 81.69 | -1.84 | -2.20% |
| American Funds New Economy R2E | |||
| REMSX | 25.43 | -0.62 | -2.38% |
| Russell Inv Emerging Markets S | |||